Roger D. Dansey

2019

In 2019, Roger D. Dansey earned a total compensation of $6.7M as Chief Medical Officer at Seattle Genetics, a 32% decrease compared to previous year.

Compensation breakdown

Bonus$150,000
Non-Equity Incentive Plan$622,675
Option Awards$2,149,091
Salary$670,900
Stock Awards$2,831,698
Other$294,460
Total$6,718,824

Dansey received $2.8M in stock awards, accounting for 42% of the total pay in 2019.

Dansey also received $150K in bonus, $622.7K in non-equity incentive plan, $2.1M in option awards, $670.9K in salary and $294.5K in other compensation.

Rankings

In 2019, Roger D. Dansey's compensation ranked 1,452nd out of 13,971 executives tracked by ExecPay. In other words, Dansey earned more than 89.6% of executives.

ClassificationRankingPercentile
All
1,452
out of 13,971
90th
Division
Manufacturing
516
out of 5,695
91st
Major group
Chemicals And Allied Products
157
out of 2,194
93rd
Industry group
Drugs
125
out of 1,880
93rd
Industry
Biological Products, Except Diagnostic Substances
27
out of 389
93rd

Pay ratio

Roger D. Dansey's Pay$6,718,824
Median Employee's Pay$222,352
Pay Ratio

30

to 1

In 2019, the annual total compensation of Roger D. Dansey was $6,718,824.

The annual total compensation of the median employee at Seattle Genetics was $222,352.

The ratio of Roger D. Dansey's pay to the pay of median employee was therefore 30 to one.

Source: SEC filing on April 1, 2020.

Dansey's colleagues

We found five more compensation records of executives who worked with Roger D. Dansey at Seattle Genetics in 2019.

2019

Clay Siegall

Seattle Genetics

Chief Executive Officer

2019

Robin Taylor

Seattle Genetics

Former Chief Commercial Officer

2019

Todd Simpson

Seattle Genetics

Chief Financial Officer

2019

Jean Liu

Seattle Genetics

General Counsel

2019

Chip Romp

Seattle Genetics

Executive Vice President, Commercial U.S

News

You may also like